α-Glucosidase-IN-69
α-Glucosidase-IN-69 (compound 5k) is a competitive α-glucosidase inhibitor with an IC50 of 26.8 µM and a Ki value of 26.0 µM. α-Glucosidase-IN-69 has the potential for the diabetes research[1].
Product Specifications
UNSPSC
12352101
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-69.html
Smiles
O=C(C(N1)=CC2=C1C=CC=C2)NCC3=CN(CC(NC4=CC=C(Br)C=C4)=O)N=N3
Molecular Formula
C20H17BrN6O2
Molecular Weight
453.29
References & Citations
[1]Mohammad Hossein Sayahi, et al. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. Sci Rep. 2024 Jul 9;14 (1) :15791.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682123-100 1x 100 µL
Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2123R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402946-500 1x 500 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC419413 20 µg
Laminin gamma 1 (LAMC1) (NM_002293) Human Over-expression Lysate
Sign In for Pricing
View Details 